The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion
暂无分享,去创建一个
G. Sauter | T. Schlomm | S. Steurer | T. Krech | C. Wittmer | R. Simon | S. Minner | M. Tsourlakis | H. Heinzer | M. Graefen | M. Kluth | C. Hube-Magg | C. Koop | C. Burdelski | N. Melling | Devi Menan